Europe Pharmacovigilance And Drug Safety Software Market Size & Outlook
Europe pharmacovigilance and drug safety software market, 2018-2030 (US$M)
Related Markets
Europe pharmacovigilance and drug safety software market highlights
- The Europe pharmacovigilance and drug safety software market generated a revenue of USD 51.5 million in 2023.
- The market is expected to grow at a CAGR of 7.1% from 2024 to 2030.
- In terms of segment, on-demand was the largest revenue generating delivery mode in 2023.
- On-Demand is the most lucrative delivery mode segment registering the fastest growth during the forecast period.
- Country-wise, Italy is expected to register the highest CAGR from 2024 to 2030.
Europe data book summary
| Market revenue in 2023 | USD 51.5 million |
| Market revenue in 2030 | USD 83.5 million |
| Growth rate | 7.1% (CAGR from 2023 to 2030) |
| Largest segment | On-demand |
| Fastest growing segment | On-Demand |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | On-Premise, On-Demand |
| Key market players worldwide | IQVIA Holdings Inc, Accenture PLC Class A, Cognizant Technology Solutions Corp Class A, Labcorp Holdings Inc, International Business Machines Corp, ArisGlobal, Icon PLC, Capgemini SE, Oracle Corp, PAREXEL |
Other key industry trends
- In terms of revenue, Europe region accounted for 26.0% of the global pharmacovigilance and drug safety software market in 2023.
- Globally, Asia Pacific is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 106.1 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Pharmacovigilance And Drug Safety Software Market Scope
Pharmacovigilance And Drug Safety Software Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Europe pharmacovigilance and drug safety software market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pharmacovigilance and drug safety software market will help companies and investors design strategic landscapes.
On-demand was the largest segment with a revenue share of 57.28% in 2023. Horizon Databook has segmented the Europe pharmacovigilance and drug safety software market based on on-premise, on-demand covering the revenue growth of each sub-segment from 2018 to 2030.
- Europe Pharmacovigilance And Drug Safety Software Delivery Mode Outlook (Revenue, USD Million, 2018-2030)
- On-Premise
- On-Demand
- Europe Pharmacovigilance And Drug Safety Software End Use Outlook (Revenue, USD Million, 2018-2030)
- Healthcare Companies (Pharmaceuticals & Biotechnology Companies)
- CROs/BPOs or PV service providers when outsourced
- Others
- Europe Pharmacovigilance And Drug Safety Software Functionality Outlook (Revenue, USD Million, 2018-2030)
- Case data collection and management
- Adverse event reporting and analysis
- Signal detection and other safety risk assessment
Reasons to subscribe to Europe pharmacovigilance and drug safety software market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Europe pharmacovigilance and drug safety software market databook
-
Our clientele includes a mix of pharmacovigilance and drug safety software market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe pharmacovigilance and drug safety software market , including forecasts for subscribers. This continent databook contains high-level insights into Europe pharmacovigilance and drug safety software market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Europe pharmacovigilance and drug safety software market size, by country, 2018-2030 (US$M)
Europe Pharmacovigilance And Drug Safety Software Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
